NIH awards $470 million to long COVID research
Long COVID remains a mystery, more than a year after the condition first arose. To find answers, the National Institutes of Health (NIH) has created a research initiative, awarding grants totaling roughly $470 million.
For many who have become ill with COVID-19 and recovered, all that remains is natural immunity. However, for others, “long COVID” becomes a fact of life, leaving many with fatigue, shortness of breath, “brain fog,” depression, and other symptoms. To study this condition, the National Institutes of Health has created the REsearching COVID to Enhance Recovery (RECOVER) Initiative and awarded roughly $470 million to create a national study population of diverse volunteers as well as support large-scale studies on long-term effects of COVID-19.1 The funding is supported by the American Rescue Plan.
The research will include children, adults, and pregnant people, who have been enrolled either during the acute or post-acute phases of infection. It is expected to look at incidence and prevalence of long COVID, symptoms, underlying causes, risk factors for having lingering symptoms, and outcomes. Data from the initiative’s cohort is expected to include clinical information, laboratory tests, and analyses of participants who were in various stages of recovery following infection. Access to this information is expected to help accelerate research.
In the press release for the program, Walter J. Koroshetz, MD, director of National Institutes of Health’s National Institute of Neurological Disorders and Stroke as well as one of the RECOVER co-chairs said, “given the range of symptoms that have been reported, intensive research using all available tools is necessary to understand what happens to stall recovery from this terrible virus. Importantly, the tissue pathology studies in RECOVER will enable in depth studies of the virus’s effects on all body systems.”
This article was originally posted on Contemporary Pediatrics®.
Reference
1.National Institutes of Health. NIH builds large nationwide study population of tens of thousands to support research on long-term effects of COVID-19. Published September 15, 2021. Accessed September 15, 2021. https://www.nih.gov/news-events/news-releases/nih-builds-large-nationwide-study-population-tens-thousands-support-research-long-term-effects-covid-19
NAID report shows maternal COVID-19 vaccination protects newborns
April 4th 2024New research led by the National Institute of Allergy and Infectious Diseases reveals sustained antibody levels in infants born to vaccinated mothers, underscoring the importance of maternal vaccination in safeguarding newborns against COVID-19.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
Decreased adolescent pregnancy and sexual health care during COVID-19 pandemic
February 13th 2024Adolescent pregnancy and sexual health care utilization declined during the COVID-19 pandemic, indicating significant disruptions in reproductive health services for young females, as highlighted in a recent study published in Pediatrics.
Read More
